Vasoprotective Actions of the Atrial Natriuretic Peptide

E-ISSN： 1875-6174|3|1|11-21

ISSN： 1568-0169

Source： Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol.3, Iss.1, 2005-01, pp. : 11-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atrial natriuretic peptide in pulmonary emboli

By Adler A. Peleg E. Swas T. Grossman E. Thaler M. Goldenberg I. Rosenthal T.

European Journal of Internal Medicine, Vol. 10, Iss. 1, 1999-05 ,pp. : 41-44

Elsevier

Access to resources Recommend Favorite

Anterior Hypothalamic Norepinephrine, Atrial Natriuretic Peptide, and Hypertension

By Oparil S. Chen Y.F. Peng N. Wyss J.M.

Frontiers in Neuroendocrinology, Vol. 17, Iss. 2, 1996-04 ,pp. : 212-246

Academic Press

Access to resources Recommend Favorite

Increased Arterial Compliance in Cirrhosis is Related to Decreased Arterial C-type Natriuretic Peptide, but not to Atrial Natriuretic Peptide

By Henriksen J. H. Gülberg V. Gerbes A. L. Bendtsen F. Møller S.

Scandinavian Journal of Gastroenterology, Vol. 38, Iss. 5, 2003-01 ,pp. : 559-564

Informa Healthcare

Access to resources Recommend Favorite

Atrial natriuretic peptide (ANP) preconditioning: what is the relevance of the antiapoptotic effects?

By Gugenheim J.

Journal of Hepatology, Vol. 39, Iss. 3, 2003-09 ,pp. : 428-430

Elsevier

Access to resources Recommend Favorite

Plasma Atrial Natriuretic Peptide in Essential Hypertension after Treatment with Irbesartan

By Kotridis Panagiotis Kokkas Basile Karamouzis Michalis Sakadamis George Kanonidis Ioannis Dadous George Karantona Chrisoula Gouli Olga Karadoumanis Joshef Papadopoulos Pavlos C. Papadopoulos Constantine L.

Blood Pressure, Vol. 11, Iss. 2, 2002-03 ,pp. : 91-94

Informa Healthcare

Access to resources Recommend Favorite